Table 9.
Data on Age-Related Penetrance (NF-pNETs) From Included Studies
| Study | No. of MEN1 Patients (pNETs) | Design | Age, y | Modality Used | Penetrance | Youngest Patient, y |
|---|---|---|---|---|---|---|
| Gonçalves et al., 2014 [53] | 19 (8) | R | 12–20 | EUS (74%) CT/MRI | 42% NF-pNETs by age 20 y | 16 |
| Goudet et al., 2015 [54] | 160 | R | 1–21 | CT/MRI/EUS | 9% NF-pNETs by age 21 y | 13 |
| Manoharan et al., 2017 [56] | 166 (8) | P | 8–18 | MRI/EUS | 1.8% NF-pNETs by age 19 y | 15 |
| Machens et al., 2007 [55] | 258 (126) | Cross | 43 (mean) | CT/MRI/EUS | Age-related penetrance dpNETs (NF-pNETs) | NA |
| Mean age 14: 4% (0%) | ||||||
| Mean age 33: 45% (18%) | ||||||
| Mean age 48: 57% (14%) | ||||||
| Mean age 64: 60% (13%) | ||||||
| Triponez et al., 2006 [7] | 579 (108) | P | CT/MRI/EUS | Penetrance dpNET (NF-pNET) | NA | |
| Age 20: 9% (3%) | ||||||
| Age 50: 53% (34%) | ||||||
| Age 80: 84% (53%) | ||||||
| Thomas-Marques et al., 2006 [51] | 51 | P | 39 (16–71) | EUS | Frequency: 54.9% in cohort | 16 |
Abbreviation: Cross, cross-sectional.